INAB IN8bio, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 6, 2026
$1,40
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,88minimo 52 sett.
$2,72massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$14M
P/E
-0.3
EPS
$-4.44
i tuoi badge
Intervallo 52 sett.
$1–$3
Rating Analisti
BUY
Prezzo Obiettivo
$7
P/E
-0.3
ROE
-90.8%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
INAB Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.40
Capitalizzazione di Mercato (MRQ)
$14M
P/E
-0.3
EPS
$-4.44
ROE
-90.8%
Intervallo 52 sett.
$1–$3
INAB Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 06 Giugno 2025 | 1-for-30 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-4.442021-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | INAB | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.3media 5 anni ≈-36.6 | ≈-36.6 | · | · | |
| P/B (MRQ) | 0.8media 5 anni ≈53.1 | ≈53.1 | 1.3 | Sottovalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -1.1media 5 anni ≈-83.0 | ≈-83.0 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.5media 5 anni ≈46.5 | ≈46.5 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | INAB | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -73.0%media 5 anni ≈-71.3% | ≈-71.3% | -89.9% | Di prim'ordine | |
| ROE | -90.8%media 5 anni ≈-94.1% | ≈-94.1% | -136.8% | Di prim'ordine | |
| ROIC | -70.5% | · | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | INAB | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 8.2media 5 anni ≈8.6 | ≈8.6 | 3.7 | Liquidità elevata | |
| Quick Ratio | 8.6media 5 anni ≈8.0 | ≈8.0 | 3.5 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
31.3%
Prossimo report
Nov 04, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 5, 2026 | $-0.25 | $-0.38 | 34.3% |
| 31 Marzo 2026 | $-0.26 | $-0.70 | 63.1% | |
| 31 Dicembre 2025 | $-0.45 | $-0.63 | 28.5% | |
| 30 Settembre 2025 | $-0.85 | $-1.25 | 32.2% | |
| 30 Giugno 2025 | $-1.24 | $-1.84 | 32.5% | |
| 31 Marzo 2025 | $-2.10 | $-2.04 | -2.9% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $17M | $17M | $14M | $7M | $5M | |
| SG&A Expense | $10M | $13M | $14M | $14M | $7M | $3M | |
| Operating Expenses | $20M | $31M | $30M | $29M | $15M | $9M | |
| Operating Income | $-19M | $-30M | $-30M | $-29M | $-15M | $-9M | |
| Interest Income | $421.0K | $230.0K | $0 | · | · | · | |
| Pretax Income | $-19M | $-31M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $-30M | $-30M | $-29M | $-15M | $-9M | |
| EPS (Basic) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | · | |
| EPS (Diluted) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | · | |
| Shares (Basic) | 4,374,328 | 1,784,890 | 29,864,932 | 20,967,955 | 9,969,733 | · | |
| Shares (Diluted) | 4,374,328 | 1,784,890 | 29,864,932 | 20,967,955 | 9,969,733 | · | |
| EBITDA | $-19M | · | $-30M | $-29M | $-15M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $11M | $21M | $18M | $37M | $18M | |
| Prepaid Expense | $788.0K | $1M | $3M | $4M | $2M | $150.0K | |
| Other Current Assets | $259.0K | $298.0K | $270.0K | $232.0K | $52.0K | $0 | |
| Current Assets | $28M | $13M | $25M | $22M | $39M | $18M | |
| PP&E (Net) | $2M | $3M | $4M | $4M | $97.0K | $186.0K | |
| PP&E (Gross) | · | · | · | · | $443.0K | $443.0K | |
| Accum. Depreciation | $3M | $2M | $1M | $321.0K | $346.0K | $257.0K | |
| Other Non-current Assets | $146.0K | $275.0K | $255.0K | $255.0K | $158.0K | $0 | |
| Total Assets | $32M | $21M | $34M | $33M | $42M | $21M | |
| Accounts Payable | $309.0K | $389.0K | $924.0K | $2M | $395.0K | $620.0K | |
| Accrued Liabilities | $2M | $1M | $3M | $2M | $1M | $2M | |
| Current Liabilities | $3M | $3M | $5M | $6M | $2M | $3M | |
| Capital Leases | $2M | $3M | $3M | $4M | $2M | $0 | |
| Total Liabilities | $5M | $6M | $9M | $10M | $4M | $3M | |
| Common Stock | $10.0K | $7.0K | $4.0K | $3.0K | $2.0K | $1.0K | |
| Paid-in Capital | $169M | $136M | $116M | $84M | $71M | $1M | |
| Retained Earnings | $-141M | $-122M | $-91M | $-61M | $-33M | $-18M | |
| Stockholders' Equity | $28M | $14M | $25M | $23M | $-38M | $-17M | |
| Liabilities + Equity | $32M | $21M | $34M | $33M | $42M | $21M | |
| Shares Outstanding | 9,766,132 | 2,416,066 | 43,287,325 | 24,545,157 | 18,781,242 | 3,764,488 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $5M | $4M | $3M | $2M | $357.0K | |
| Deferred Tax | $-2M | $-6M | $-6M | $-5M | $-5M | $-3M | |
| Operating Cash Flow | $-13M | $-24M | $-23M | $-24M | $-14M | $-7M | |
| Investing Cash Flow | $0 | $-187.0K | $-600.0K | $-4M | $-309.0K | $0 | |
| Stock Issued | $9M | $4M | $14M | $10M | $36M | $499.0K | |
| Net Stock Activity | $9M | · | $14M | $10M | $36M | · | |
| Financing Cash Flow | $29M | $14M | $27M | $9M | $33M | $25M | |
| Net Change in Cash | $16M | $-10M | $3M | $-19M | $19M | $17M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -73.0% | · | -89.9% | -75.8% | -46.4% | · | |
| ROE | -90.8% | · | -140.6% | -109.1% | -36.1% | · | |
| ROIC | -70.5% | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.8 | · | 4.6 | 3.8 | 17.3 | · | |
| Quick Ratio | 8.6 | · | 3.9 | 3.1 | 16.4 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.82 | · | $0.58 | $0.93 | $2.03 | · | |
| Cash Flow / Share | $-2.91 | · | $-0.78 | $-1.15 | · | · | |
| Cash / Share | $2.77 | · | $0.49 | $0.74 | $1.97 | · | |
| EPS (TTM) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-30M | $-30M | $-29M | $-15M | · | |
| Market Cap | $23M | · | $1.79B | $1.70B | $2.47B | · | |
| P/E | -0.5 | -0.5 | -41.4 | -51.0 | -89.6 | · | |
| P/B | 0.8 | · | 71.9 | 74.8 | 64.8 | · | |
| P / Tangible Book | 0.8 | 38.6 | 71.9 | 74.8 | · | · | |
| P / Cash Flow | -1.8 | · | -76.8 | -70.5 | -183.1 | · | |
| Earnings Yield | -189.7% | -221.1% | -2.4% | -2.0% | -1.1% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $3M | $2M | $2M | $3M | $4M | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| SG&A Expense | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Operating Expenses | $5M | $5M | $5M | $4M | $5M | $6M | $6M | $7M | $9M | $9M | $8M | $7M | $8M | $8M | $8M | $7M | |
| Operating Income | $-5M | $-5M | $-5M | $-4M | $-5M | $-6M | $-6M | $-7M | $-9M | $-9M | $-8M | $-7M | $-8M | $-8M | $-8M | $-7M | |
| Interest Income | $154.0K | $176.0K | $91.0K | $113.0K | $107.0K | $110.0K | $64.0K | $23.0K | $60.0K | $83.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-5M | $-5M | $-5M | $-4M | $-5M | $-6M | $-6M | $-7M | $-9M | $-9M | $-8M | $-7M | $-8M | $-8M | $-8M | $-7M | |
| EPS (Basic) | $-0.25 | $-0.26 | $-2.28 | $-0.85 | $-1.24 | $-2.16 | $-6.85 | $-4.49 | $-5.51 | $-0.20 | $-0.20 | $-0.23 | $-0.27 | $-0.30 | $-0.31 | $-0.34 | |
| EPS (Diluted) | $-0.25 | $-0.26 | $-2.28 | $-0.85 | $-1.24 | $-2.16 | $-6.85 | $-4.49 | $-5.51 | $-0.20 | $-0.20 | $-0.23 | $-0.27 | $-0.30 | $-0.31 | $-0.34 | |
| Shares (Basic) | 19,467,091 | 19,467,114 | · | 4,537,683 | 4,119,153 | 2,575,325 | · | 1,577,363 | 1,566,951 | 43,287,325 | · | 31,545,783 | 28,472,346 | 24,732,580 | · | 21,661,544 | |
| Shares (Diluted) | 19,467,091 | 19,467,114 | · | 4,537,683 | 4,119,153 | 2,575,325 | · | 1,577,363 | 1,566,951 | 43,287,325 | · | 31,545,783 | 28,472,346 | 24,732,580 | · | 21,661,544 | |
| EBITDA | $-5M | $-5M | · | $-4M | $-5M | $-6M | · | $-7M | $-9M | $-9M | · | $-7M | $-8M | $-8M | · | $-7M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $22M | $27M | $11M | $13M | $12M | $11M | $4M | $10M | $13M | $21M | $13M | $17M | $11M | $18M | $28M | |
| Prepaid Expense | $540.0K | $721.0K | $788.0K | $1M | $515.0K | $837.0K | $1M | $3M | $2M | $3M | $3M | $4M | $2M | $4M | $4M | $2M | |
| Other Current Assets | $364.0K | $395.0K | $259.0K | $346.0K | $367.0K | $427.0K | $298.0K | $177.0K | $529.0K | $539.0K | $270.0K | $262.0K | $277.0K | $601.0K | $232.0K | · | |
| Current Assets | $18M | $23M | $28M | $12M | $14M | $13M | $13M | $7M | $13M | · | $25M | $17M | $19M | $14M | $22M | $30M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $350.0K | |
| Accum. Depreciation | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $807.0K | $564.0K | $321.0K | $417.0K | |
| Other Non-current Assets | $102.0K | $129.0K | $146.0K | $169.0K | $275.0K | $275.0K | $275.0K | $324.0K | $320.0K | · | $255.0K | $255.0K | $255.0K | $255.0K | $255.0K | $231.0K | |
| Total Assets | $22M | $26M | $32M | $17M | $19M | $20M | $21M | $16M | $22M | · | $34M | $26M | $30M | $25M | $33M | $38M | |
| Accounts Payable | $444.0K | $449.0K | $309.0K | $204.0K | $379.0K | $575.0K | $389.0K | $1M | $1M | · | $924.0K | $748.0K | $585.0K | $870.0K | $2M | $1M | |
| Accrued Liabilities | $761.0K | $681.0K | $2M | $418.0K | $635.0K | $1M | $1M | $769.0K | $2M | $895.0K | $3M | $2M | $2M | $1M | $2M | $3M | |
| Current Liabilities | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $5M | · | $5M | $5M | $4M | $4M | $6M | $5M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | |
| Total Liabilities | $3M | $3M | $5M | $4M | $4M | $6M | $6M | $7M | $9M | · | $9M | $8M | $8M | $8M | $10M | $9M | |
| Common Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $7.0K | $5.0K | $5.0K | · | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $169M | $169M | $169M | $149M | $148M | $141M | $136M | $124M | $122M | · | $116M | $101M | $98M | $86M | $84M | $83M | |
| Retained Earnings | $-151M | $-146M | $-141M | $-136M | $-132M | $-127M | $-122M | $-115M | $-108M | · | $-91M | $-84M | $-76M | $-69M | $-61M | $-53M | |
| Stockholders' Equity | $18M | $23M | $28M | $13M | $15M | $14M | $14M | $9M | $14M | $18M | $25M | $18M | $22M | $17M | $23M | $30M | |
| Liabilities + Equity | $22M | $26M | $32M | $17M | $19M | $20M | $21M | $16M | $22M | · | $34M | $26M | $30M | $25M | $33M | $38M | |
| Shares Outstanding | 9,853,121 | 9,847,089 | 9,766,132 | 4,589,196 | 4,078,139 | 81,258,763 | 2,416,066 | 46,786,948 | 46,434,656 | · | 43,287,325 | 31,975,929 | 30,606,119 | 24,960,869 | 24,545,157 | 24,502,157 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $352.0K | $401.0K | $711.0K | $692.0K | $955.0K | $831.0K | $825.0K | $2M | $1M | $1M | $1M | $1M | $1M | $859.0K | $922.0K | $897.0K | |
| Operating Cash Flow | $-4M | $-5M | $-2M | $-4M | $-4M | $-3M | $-4M | $-6M | $-6M | $-8M | $-5M | $-6M | $-5M | $-7M | $-8M | $-6M | |
| CapEx | · | · | · | $0 | $0 | $0 | · | $0 | $21.0K | $50.0K | · | $0 | $36.0K | $371.0K | · | $39.0K | |
| Investing Cash Flow | $-233.0K | $-9.0K | $0 | $0 | $0 | $0 | $-33.0K | $0 | $-83.0K | $-71.0K | $-72.0K | $-77.0K | $-22.0K | $-429.0K | $-1M | $-2M | |
| Stock Issued | $0 | $0 | $102.0K | $1M | $4M | $4M | $4M | $-4M | $4M | $0 | $63.0K | $2M | $12M | $722.0K | $9M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $4M | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-51.0K | $-195.0K | $18M | $989.0K | $5M | $4M | $11M | $-105.0K | $3M | $-277.0K | $13M | $2M | $11M | $547.0K | $-253.0K | $9M | |
| Net Change in Cash | $-4M | $-5M | $16M | $-3M | $1M | $771.0K | $7M | $-6M | $-3M | $-8M | $8M | $-4M | $6M | $-7M | $-9M | $2M | |
| Free Cash Flow | · | · | · | · | · | $-3M | · | · | · | $-8M | · | · | · | $-8M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -23.3% | -22.1% | · | -23.5% | -24.3% | -24.9% | · | -33.6% | -33.1% | · | · | -22.2% | -25.4% | -24.6% | · | -17.3% | |
| ROE | -28.5% | -27.8% | · | -35.4% | -35.3% | -35.4% | · | -53.8% | -48.7% | -49.9% | · | -30.3% | -31.9% | -30.3% | · | -20.4% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.2 | 10.5 | · | 6.9 | 7.0 | 4.3 | · | 1.8 | 2.7 | · | · | 3.5 | 5.1 | 3.8 | · | 6.1 | |
| Quick Ratio | 8.0 | 10.2 | · | 6.3 | 6.8 | 4.0 | · | 1.1 | 2.1 | · | · | 2.7 | 4.5 | 2.9 | · | 5.6 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.86 | $2.31 | · | $2.87 | $3.74 | $0.17 | · | $0.18 | $0.29 | · | · | $0.56 | $0.71 | $0.67 | · | $1.21 | |
| Cash Flow / Share | · | $-0.25 | · | · | · | $-0.04 | · | · | · | $-0.18 | · | · | · | $-0.30 | · | · | |
| Cash / Share | $1.82 | $2.23 | · | $2.33 | $3.24 | $0.15 | · | $0.09 | $0.22 | · | · | $0.40 | $0.56 | $0.44 | · | $1.13 | |
| EPS (TTM) | $-3.64 | $-4.63 | · | $-11.10 | $-14.74 | $-19.01 | · | $-10.40 | $-6.14 | $-0.90 | · | $-1.11 | $-1.22 | $-1.33 | · | $-1.26 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-19M | · | $-21M | $-24M | $-27M | · | $-32M | $-32M | $-31M | · | $-30M | $-30M | $-30M | · | $-27M | |
| Market Cap | $14M | $15M | · | $10M | $9M | $405M | · | $379M | $1.18B | · | · | $998M | $1.41B | $973M | · | $1.48B | |
| P/E | -0.4 | -0.3 | · | -0.2 | -0.1 | -0.3 | · | -0.8 | -4.1 | -39.3 | · | -28.1 | -37.9 | -29.3 | · | -48.1 | |
| P/B | 0.8 | 0.6 | · | 0.8 | 0.6 | 29.2 | · | 44.1 | 86.6 | · | · | 56.2 | 64.9 | 58.0 | · | 50.2 | |
| P / Tangible Book | 0.8 | 0.6 | · | 0.8 | 0.6 | 29.2 | · | 44.1 | 86.6 | · | · | 56.2 | 64.9 | 58.0 | · | 50.2 | |
| P / Cash Flow | · | -2.9 | · | · | · | -129.6 | · | · | · | · | · | · | · | -130.9 | · | · | |
| Earnings Yield | -258.2% | -312.8% | · | -511.5% | -705.3% | -381.7% | · | -128.4% | -24.2% | -2.5% | · | -3.6% | -2.6% | -3.4% | · | -2.1% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utile netto | $-19M | $-30M | $-30M | $-29M | $-15M |
| EPS Diluito | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 8.8 | · | 4.6 | 3.8 | 17.3 |
| Quick Ratio | 8.6 | · | 3.9 | 3.1 | 16.4 |
Nessun dato per questo bilancio
Dati fondamentali insufficienti per creare questo bilancio al momento.
Proprietari istituzionali (13F) 23 filer · $5.5M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
23
Valore detenuto
$5.5M
Nuove posizioni
3
Posizioni chiuse
1
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 3 (-1 vs trimestre precedente) | 1 (-3 vs trimestre precedente) | 5 (+2 vs trimestre precedente) | 3 (-3 vs trimestre precedente) | +37K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | $1.331.490 | 944.319 | 24,22% | Azioni |
| FRANKLIN RESOURCES INC | $1.289.489 | 914.531 | 23,46% | Azioni |
| 683 Capital Management, LLC | $1.021.738 | 724.637 | 18,59% | Azioni |
| Stonepine Capital Management, LLC | $980.355 | 695.287 | 17,83% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $126.544 | 88.865 | 2,30% | Azioni |
| BIOS Capital Management, LP | $114.149 | 80.957 | 2,08% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $102.298 | 72.550 | 1,86% | Azioni |
| CITADEL ADVISORS LLC | $88.908 | 63.055 | 1,62% | Azioni |
| OPPENHEIMER & CO INC | $88.889 | 63.042 | 1,62% | Azioni |
| TWO SIGMA ADVISERS, LP | $85.061 | 36.351 | 1,55% | Azioni |
| VANGUARD GROUP INC | $66.335 | 28.348 | 1,21% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $62.044 | 43.570 | 1,13% | Azioni |
| CAPTRUST FINANCIAL ADVISORS | $46.946 | 33.295 | 0,85% | Azioni |
| Texas Capital Bank Wealth Management Services Inc | $34.412 | 24.406 | 0,63% | Azioni |
| NORTHERN TRUST CORP | $30.645 | 21.734 | 0,56% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $17.061 | 12.100 | 0,31% | Azioni |
| Tower Research Capital LLC (TRC) | $5.271 | 3.738 | 0,10% | Azioni |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $3.927 | 2.785 | 0,07% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $1.044 | 768 | 0,02% | Azioni |
| BlackRock, Inc. | $118 | 84 | 0,00% | Azioni |
| Rockefeller Capital Management L.P. | $117 | 83 | 0,00% | Azioni |
| BARCLAYS PLC | $39 | 28 | 0,00% | Azioni |
| UBS Group AG | $1 | 1 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| EMILY FAIRBAIRN, Malcom Fairbairn, Malcom and Emily Fairbairn 2010 CRUT ×2 depositi | 29 Maggio 2026 | 2,20% | Modifica | · | SEC |
| BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III QP, LP, BIOS Fund III NT, LP, Bios Clinical Opportunity Fund, LP, BP Directors, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Bios Equity COF, LP, Cavu Management, LP, BIOS Capital Management, LP, Cavu Advisors, LLC, BIOS Advisors GP, LLC, Kreis Leslie W., Fletcher Aaron G.L. ×5 depositi | 29 Dicembre 2025 | 2,90% | Modifica | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 12 insider · 5 dirigenti · 8 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| William Tai-Wei Ho | CEO | 09 Maggio 2026 A | 121.168 | 0 | 0 | $0 |
| McCall Patrick | CHIEF FINANCIAL OFFICER | 09 Maggio 2026 A | 9.482 | 0 | 0 | $0 |
| Kate Rochlin | President and COO | 09 Maggio 2026 A | 9.085 | 0 | 0 | $0 |
| Lawrence Lamb | EVP and CSO | 09 Maggio 2026 A | 101.369 | 0 | 0 | $0 |
| Trishna Goswami | Chief Medical Officer | 04 Settembre 2024 A | 6.729 | 0 | 0 | $0 |
| Jeremy R. Graff | Direttore | 09 Maggio 2026 A | 4.549 | 0 | 0 | $0 |
| Luba Greenwood | Direttore | 09 Maggio 2026 A | 7.826 | 0 | 0 | $0 |
| Corinne Epperly | Direttore | 09 Maggio 2026 A | 81.967 | 0 | 0 | $0 |
| EMILY FAIRBAIRN | Direttore | 09 Maggio 2026 A | 724.637 | 0 | 0 | $0 |
| Peter C. Brandt | Direttore | 09 Maggio 2026 A | 95.181 | 0 | 0 | $0 |
| Alan S. Roemer | Direttore | 22 Dicembre 2025 A | 49.514 | 0 | 0 | $0 |
| Travis Whitfill | Direttore | 19 Dicembre 2024 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 2 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
INAB Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 10 analisti
COMPRA
Target mediano
$6.00
+328,6%
2 20,0%
Acquisto forte
7 70,0%
Compra
1 10,0%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-09-30Target medio $7.00 +400,0%
← Sotto tutti i target
Prezzo attuale $1.40
Basso$5.00
Media$7.00
Alto$10.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026